KR930701619A - 인체 면역 결핍 바이러스의 gag 단백질 전구체 p55에 대한 단일클론 항체 - Google Patents
인체 면역 결핍 바이러스의 gag 단백질 전구체 p55에 대한 단일클론 항체Info
- Publication number
- KR930701619A KR930701619A KR1019920703048A KR920703048A KR930701619A KR 930701619 A KR930701619 A KR 930701619A KR 1019920703048 A KR1019920703048 A KR 1019920703048A KR 920703048 A KR920703048 A KR 920703048A KR 930701619 A KR930701619 A KR 930701619A
- Authority
- KR
- South Korea
- Prior art keywords
- hiv
- cleavage site
- antibody
- gag
- fragment
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title claims abstract 6
- 101710177291 Gag polyprotein Proteins 0.000 title claims 5
- 101710125418 Major capsid protein Proteins 0.000 title claims 5
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 108010016183 Human immunodeficiency virus 1 p16 protease Proteins 0.000 claims abstract description 16
- 238000003776 cleavage reaction Methods 0.000 claims abstract description 14
- 230000007017 scission Effects 0.000 claims abstract description 14
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims abstract description 8
- 102100036089 Fascin Human genes 0.000 claims abstract 15
- 239000012634 fragment Substances 0.000 claims abstract 11
- 210000004408 hybridoma Anatomy 0.000 claims abstract 8
- 210000004027 cell Anatomy 0.000 claims abstract 7
- 206010035226 Plasma cell myeloma Diseases 0.000 claims abstract 4
- 230000002401 inhibitory effect Effects 0.000 claims abstract 4
- 201000000050 myeloid neoplasm Diseases 0.000 claims abstract 4
- 241001465754 Metazoa Species 0.000 claims abstract 3
- 238000002955 isolation Methods 0.000 claims abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract 3
- 238000000746 purification Methods 0.000 claims abstract 3
- 238000012216 screening Methods 0.000 claims abstract 3
- 230000004927 fusion Effects 0.000 claims abstract 2
- 238000012544 monitoring process Methods 0.000 claims abstract 2
- 102000037865 fusion proteins Human genes 0.000 claims description 12
- 108020001507 fusion proteins Proteins 0.000 claims description 12
- 238000004458 analytical method Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 8
- 102000004190 Enzymes Human genes 0.000 claims 4
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102000005936 beta-Galactosidase Human genes 0.000 claims 4
- 108010005774 beta-Galactosidase Proteins 0.000 claims 4
- 229940124452 immunizing agent Drugs 0.000 claims 3
- 239000003550 marker Substances 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 238000012360 testing method Methods 0.000 claims 2
- 108010010369 HIV Protease Proteins 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 210000000628 antibody-producing cell Anatomy 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000012620 biological material Substances 0.000 claims 1
- 239000012496 blank sample Substances 0.000 claims 1
- 235000010633 broth Nutrition 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003593 chromogenic compound Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 230000003100 immobilizing effect Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 238000003118 sandwich ELISA Methods 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 101710172711 Structural protein Proteins 0.000 abstract 2
- 230000009257 reactivity Effects 0.000 abstract 2
- 210000004989 spleen cell Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP90110461 | 1990-06-01 | ||
| GB90110461.2 | 1990-06-01 | ||
| GB90113658.0 | 1990-07-17 | ||
| EP90113658 | 1990-07-17 | ||
| EP90122813 | 1990-11-29 | ||
| GB90122813.0 | 1990-11-29 | ||
| PCT/EP1991/000947 WO1991019000A1 (fr) | 1990-06-01 | 1991-05-21 | ANTICORPS MONOCLONAL ANTAGONISTE DE LA PROTEINE PRECURSEUR p55 GAG DU VIRUS D'IMMUNODEFICIENCE HUMAINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930701619A true KR930701619A (ko) | 1993-06-12 |
Family
ID=27233285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920703048A KR930701619A (ko) | 1990-06-01 | 1991-05-21 | 인체 면역 결핍 바이러스의 gag 단백질 전구체 p55에 대한 단일클론 항체 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0535007B1 (fr) |
| JP (1) | JPH05507409A (fr) |
| KR (1) | KR930701619A (fr) |
| AT (1) | ATE126238T1 (fr) |
| CA (1) | CA2083399A1 (fr) |
| DE (1) | DE69112059T2 (fr) |
| DK (1) | DK0535007T3 (fr) |
| ES (1) | ES2075958T3 (fr) |
| GR (1) | GR3017444T3 (fr) |
| IE (1) | IE68597B1 (fr) |
| WO (1) | WO1991019000A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9929674D0 (en) * | 1999-12-15 | 2000-02-09 | Novartis Res Found | Protease-activated receptor (PAR) modulator assays |
| US6821744B2 (en) | 2002-10-29 | 2004-11-23 | Roche Diagnostics Operations, Inc. | Method, assay, and kit for quantifying HIV protease inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4886742A (en) * | 1987-06-15 | 1989-12-12 | Coulter Corporation | Enzyme immunoassay for detecting HIV antigens in human sera |
| US4888290A (en) * | 1987-11-06 | 1989-12-19 | Coulter Corporation | Monoclonal antibody specific to HIV antigens |
-
1991
- 1991-05-21 DE DE69112059T patent/DE69112059T2/de not_active Expired - Fee Related
- 1991-05-21 KR KR1019920703048A patent/KR930701619A/ko not_active Application Discontinuation
- 1991-05-21 JP JP91509722A patent/JPH05507409A/ja active Pending
- 1991-05-21 EP EP91909824A patent/EP0535007B1/fr not_active Expired - Lifetime
- 1991-05-21 CA CA002083399A patent/CA2083399A1/fr not_active Abandoned
- 1991-05-21 DK DK91909824.4T patent/DK0535007T3/da active
- 1991-05-21 ES ES91909824T patent/ES2075958T3/es not_active Expired - Lifetime
- 1991-05-21 AT AT91909824T patent/ATE126238T1/de not_active IP Right Cessation
- 1991-05-21 WO PCT/EP1991/000947 patent/WO1991019000A1/fr active IP Right Grant
- 1991-05-31 IE IE186691A patent/IE68597B1/en not_active IP Right Cessation
-
1995
- 1995-09-20 GR GR950402570T patent/GR3017444T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE68597B1 (en) | 1996-06-26 |
| DE69112059D1 (de) | 1995-09-14 |
| JPH05507409A (ja) | 1993-10-28 |
| IE911866A1 (en) | 1991-12-04 |
| EP0535007A1 (fr) | 1993-04-07 |
| ATE126238T1 (de) | 1995-08-15 |
| DK0535007T3 (da) | 1995-09-25 |
| CA2083399A1 (fr) | 1991-12-02 |
| WO1991019000A1 (fr) | 1991-12-12 |
| ES2075958T3 (es) | 1995-10-16 |
| GR3017444T3 (en) | 1995-12-31 |
| DE69112059T2 (de) | 1996-02-29 |
| EP0535007B1 (fr) | 1995-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4935343A (en) | Monoclonal antibodies for interleukin-1β | |
| US4656253A (en) | Monoclonal antibodies against alveolar surfactant protein | |
| WO2016080701A1 (fr) | Anticorps reconnaissant la nucléocapside du coronavirus du syndrome respiratoire du moyen-orient et utilisation de celui-ci | |
| JPH02500004A (ja) | 非還元・非酵素的糖鎖形成蛋白に対するモノクローナル抗体 | |
| RU2366663C2 (ru) | Устройство для иммунного анализа с использованием антитела к вирусу гриппа типа b | |
| JP2012082210A (ja) | Ａｄａｍｔｓ１３活性検定用抗体及び活性検定方法 | |
| KR930701619A (ko) | 인체 면역 결핍 바이러스의 gag 단백질 전구체 p55에 대한 단일클론 항체 | |
| CA2150497C (fr) | Inhibiteur de la peroxydase de raifort et anticorps monoclonaux anti-inhibiteur | |
| WO1987001119A1 (fr) | Anticorps monoclonaux reactifs contre le campylobacter pyloridis | |
| US8349569B2 (en) | Anti-fibronectin fragment monoclonal antibody | |
| US6596846B2 (en) | Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26) | |
| US20080293036A1 (en) | Monoclonal Antibodies to Hiv-1 and Methods of Using Same | |
| JP2518602B2 (ja) | ヒトプロテインｓに対するモノクロ―ナル抗体を用いた免疫学的測定試薬及びキット | |
| WO1987007147A1 (fr) | Methode pour produire des anticorps monoclonaux a un complexe immunogenique anticorps-antigene | |
| Lo et al. | Analysis of antibody reactivities in ELISA using protein blots as antigen substrates: S-ELISA | |
| EP0842197A2 (fr) | Anticorps a large specificite | |
| JPH07117534B2 (ja) | ヒトプロテインｓに対するモノクローナル抗体を用いた免疫学的測定試薬及びキット | |
| JPS62180270A (ja) | インタ−フエロン−γの免疫化学的測定法および測定用試薬 | |
| ISHIJIMA et al. | Preparation and characterization of monoclonal antibodies against phosphoenolpyruvate carboxylase of Escherichia coli | |
| JPH0940700A (ja) | モノクロナール抗体 | |
| JPH05211888A (ja) | マウスインターロイキン−６レセプターに対する抗体及びその使用 | |
| JP2002306164A (ja) | エボラウイルスを認識するモノクローナル抗体 | |
| EP0472599A1 (fr) | Procedes et systeme de determination de la presence d'un antigene de pneumocystis carinii dans le sang | |
| JPH05268987A (ja) | 抗ヒトセルロプラスミンモノクローナル抗体、それを用いたヒトセルロプラスミンの検出方法及びそれを産生するハイブリドーマ | |
| JPH067190A (ja) | 抗モルヒネ抗体の抗イディオタイプ抗体、その製法及びモルヒネの測定法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |